ibrutinib,venetoclax
abbvie,janssen,roche
['cll', ' ibru', 'glow']
more data on 1st line ibrutinib+ven in cll tx. comprehensive pharmacist serviced critical for #cll pts given need for adherence support, tox mitigation, and medication access challenges in real-world settings. #ash22 #oncopharm 
Assistant Professor at UNC Eshelman School of Pharmacy. #adherence, #leukemia, #globalhealth, #access, #impsci, #equity